| Primary information |
|---|
| ID | 13219 |
| Uniprot ID | Q7LZ09 |
| Description | Lebetin-2-alpha (L2alpha) [Cleaved into- Lebetin-1-alpha (L1alpha); Lebetin-1-beta (L1beta); Lebetin-1-gamma (L1gamma); Lebetin-2-beta (L2beta)] |
| Organism | Macrovipera lebetina |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria (diapsids); Lepidosauria (lepidosaurs); Squamata (squamates); Bifurcata (split-tongued squamates); Unidentata; Episquamata; Toxicofera; Serpentes (snakes); Colubroidea; Viperidae; Viperinae (vipers); Macrovipera; Macrovipera lebetina (Levantine viper) (Vipera |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the natriuretic peptide family. |
| Tissue Specificity | Expressed by the venom gland. |
| Post Translational Modification | NA |
| Function | [Lebetin-1-alpha]- inhibits platelet aggregation induced by thrombin; collagen and PAF-acether |
| Length | 38 |
| Molecular Weight | 3 |
| Name | Lebetin-2-alpha |
| Sequence | GDNKPPKKGPPNGCFGHKIDRIGSHSGLGCNKVDDNKG |
| Sequence map | 912 |
| PDB ID | 8769304; 9839678; 11910186; |
| Drugpedia | 1Q01; |
| Receptor | NA |
| Domain | NA |
| Pharmaceutical Use | NA
|